Edition:
United States

Anthem Inc (ANTM.N)

ANTM.N on New York Stock Exchange

221.31USD
9:32am EST
Change (% chg)

$0.89 (+0.40%)
Prev Close
$220.42
Open
$220.67
Day's High
$221.31
Day's Low
$220.67
Volume
6,525
Avg. Vol
366,980
52-wk High
$222.21
52-wk Low
$140.51

Chart for

About

Anthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred... (more)

Overall

Beta: 0.76
Market Cap(Mil.): $56,595.15
Shares Outstanding(Mil.): 256.76
Dividend: 0.70
Yield (%): 1.27

Financials

  Industry Sector
P/E (TTM): -- 23.16 15.54
EPS (TTM): -- -- --
ROI: -- -0.08 11.80
ROE: -- 16.10 15.75

BRIEF-Anthem announces pricing of its tender offer for any and all of its 7 pct notes due 2019

* Anthem announces pricing of its tender offer for any and all of its 7.000 pct notes due 2019

Nov 20 2017

Fitch Rates Anthem's Planned Issue 'BBB'; Affirms Existing Ratings; Outlook Negative

(The following statement was released by the rating agency) CHICAGO, November 14 (Fitch) Fitch Ratings has assigned a 'BBB' rating to Anthem Inc.'s (ANTM) planned issue of new senior notes of various maturities. The rating on the planned issuance is equivalent to Fitch's ratings on ANTM's currently outstanding senior notes. Fitch has concurrently affirmed ANTM's previously outstanding ratings and maintained their Negative Outlook. A full list of rating actions can be found at the end of this

Nov 14 2017

BRIEF-Anthem launches cash tender offers for certain outstanding debt securities

* Anthem launches cash tender offers for certain outstanding debt securities

Nov 14 2017

BRIEF-Anthem files preliminary prospectus supplement related to potential notes offering

* Anthem Inc files preliminary prospectus supplement related to a potential five-part notes offering - SEC filing Source text: (http://bit.ly/2iTLr0B) Further company coverage:

Nov 14 2017

BRIEF-Anthem Inc issues positive coverage decision for balloon sinus dilation

* Anthem Inc issues positive coverage decision for balloon sinus dilation

Nov 13 2017

The 20 percent club: hedge fund stars of an industry rebound

NEW YORK A group of prominent hedge funds have roared back with market-trouncing returns in 2017, helping the industry score its best performance in at least four years in a surprise rebound for an often maligned pocket of Wall Street.

Nov 10 2017

The 20 percent club: hedge fund stars of an industry rebound

NEW YORK, Nov 10 A group of prominent hedge funds have roared back with market-trouncing returns in 2017, helping the industry score its best performance in at least four years in a surprise rebound for an often maligned pocket of Wall Street.

Nov 10 2017

Health insurer Anthem eases restrictions on Sarepta's Duchenne treatment

NEW YORK Health insurer Anthem Inc has eased access to Sarepta Therapeutics' treatment for Duchenne muscular dystrophy, and on Thursday changed its reimbursement policy on its website to "medically necessary."

Nov 09 2017

UPDATE 1-Health insurer Anthem eases restrictions on Sarepta's Duchenne treatment

NEW YORK, Nov 9 Health insurer Anthem Inc has eased access to Sarepta Therapeutics' treatment for Duchenne muscular dystrophy, and on Thursday changed its reimbursement policy on its website to "medically necessary."

Nov 09 2017

Health insurer Anthem eases restrictions on Sarepta's Duchenne treatment

NEW YORK, Nov 9 Health insurer Anthem Inc has eased access to Sarepta Therapeutics' treatment for Duchenne muscular dystrophy, and on Thursday changed its reimbursement policy on its website to "medically necessary."

Nov 09 2017

Competitors

  Price Chg
Humana Inc (HUM.N) $238.30 --
Aetna Inc (AET.N) $176.30 +0.06
Magellan Health Inc (MGLN.OQ) $83.65 --
CIGNA Corporation (CI.N) $200.72 -1.27
UnitedHealth Group Inc (UNH.N) $211.22 -1.38

Earnings vs. Estimates